Search results
Getting COVID-19 Could Weaken Your Immune System
Time via Yahoo News· 1 year agoIllustration of a T cell targeting SARS-CoV-2 particles. Credit - Science Photo Library—Getty Images Even relatively easy bouts with COVID-19 can still...
COVID left some with damaged immune response, study finds
CBS News via Yahoo News· 1 year agoA key piece of the body's immune response to COVID-19 looks to have been damaged in people who...
QIAGEN (QGEN) Publishes New Data on QuantiFERON TB Testing
Zacks via Yahoo Finance· 10 months agoQIAGEN QGEN recently made progress in tuberculosis (TB) testing. The company announced that a new,...
People vaccinated against COVID after infection still at risk, study says. Here’s why
Miami Herald via Yahoo News· 1 year agoPeople infected with the coronavirus before getting their first two COVID-19 shots may still be at...
Novavax (NVAX) Reports Positive Data on COVID/FLU Combo Jab Study
Zacks via Yahoo Finance· 2 years agoNovavax NVAX announced positive top-line results from a phase I/II study evaluating the safety and...
Apexigen Touts New Positive Sotigalimab Data Showing Expanded Anti-Tumor Responses
Benzinga via Yahoo Finance· 1 year agoApexigen Inc (NASDAQ: APGN) announced the presentation of new data from Phase 2 multicenter clinical...
Why Are IN8bio Stock Is Soaring More Than 100% Today
Benzinga via Yahoo Finance· 1 year agoIN8bio Inc (NASDAQ: INAB) announced new data from the Phase 1 investigator-sponsored trial of INB-100 in leukemia patients. The data showed that 100% of...
Gamida Cell Ltd. (GMDA) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoPlease be advised that this call is being recorded at Gamida Cell's request. Now, I would like to...
Evaxion Biotech Highlights Promising Data From Personalized Cancer Immunotherapy
Benzinga via Yahoo Finance· 1 year agoEvaxion Biotech A/S (NASDAQ: EVAX) has announced interim safety and immunogenicity data from the...
Inovio Pharma Highlights Early Data From Experimental Drug For Respiratory Tract Disease
Benzinga via Yahoo Finance· 2 years agoInovio Pharmaceuticals Inc (NASDAQ: INO) announced interim results from an ongoing Phase 1/2 trial...